These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1950438)
1. [Quinolones! or quinolones?]. Decazes JM Acta Leprol; 1991; 7(4):313-4. PubMed ID: 1950438 [No Abstract] [Full Text] [Related]
2. The chemotherapy of leprosy. Part 2. Ellard GA Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):82-94. PubMed ID: 2030319 [No Abstract] [Full Text] [Related]
3. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up. Ganapati R; Revankar CR; Pai VV; Kingsley S Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413 [No Abstract] [Full Text] [Related]
4. Single-dose treatment for paucibacillary leprosy; field implications. Revankar CR; Pai VV; Samy MS; Ganapati R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415 [No Abstract] [Full Text] [Related]
5. Single-dose treatment for paucibacillary leprosy; clinical problems and management. Pai VV; Bulchand HO; Revankar CR; Ganapati R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414 [No Abstract] [Full Text] [Related]
6. Studies on the development of novel anti-leprous chemotherapeutics using nude mice with special reference to a new quinolone carboxylic acid, AT-4140. Tsutsumi S; Gidoh M Nihon Rai Gakkai Zasshi; 1989; 58(4):250-8. PubMed ID: 2489283 [TBL] [Abstract][Full Text] [Related]
7. The difficulty in diagnosis and treatment of leprosy. Forno C; Häusermann P; Hatz C; Itin P; Blum J J Travel Med; 2010; 17(4):281-3. PubMed ID: 20636605 [TBL] [Abstract][Full Text] [Related]
8. [The role of the new quinolones in the treatment and prevention of tuberculosis and other infections caused by mycobacterium]. Ciruelos E; Zalazaín R; Sobradillo V Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():34-8. PubMed ID: 10563109 [No Abstract] [Full Text] [Related]
9. Mycobacteria and the new quinolones. Leysen DC; Haemers A; Pattyn SR Antimicrob Agents Chemother; 1989 Jan; 33(1):1-5. PubMed ID: 2540705 [No Abstract] [Full Text] [Related]
10. In vitro and in vivo activities of ofloxacin against Mycobacterium leprae infection induced in mice. Saito H; Tomioka H; Nagashima K Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):560-2. PubMed ID: 3546546 [TBL] [Abstract][Full Text] [Related]
12. Absence of enhancing effect of trimethoprim on the activity of a sulfonamide against Mycobacterium leprae. Pattyn SR; Verdoolaege-Van Loo G Int J Lepr Other Mycobact Dis; 1972; 40(3):320. PubMed ID: 4574275 [No Abstract] [Full Text] [Related]
13. Screening of drugs for activity against Mycobacterium leprae. Baohong J; Matsuo Y; Colston MJ Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576 [No Abstract] [Full Text] [Related]
14. Chemotherapy of the mycobacterial diseases--leprosy and tuberculosis. Krenzien HN Indian J Chest Dis Allied Sci; 1982; 24(2-3):223-32. PubMed ID: 6762341 [No Abstract] [Full Text] [Related]
15. Clofazimine (Lamprene) in leprosy. Drug Ther Bull; 1970 Jan; 8(2):7-8. PubMed ID: 4903794 [No Abstract] [Full Text] [Related]
16. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment. Shepard CC; Levy L; Fasal P Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029 [No Abstract] [Full Text] [Related]
17. [Action of desoxyfructo-serotonin on Mycobacterium leprae. Results of inoculation of human biopsy specimens in the mouse after a year of treatment]. Ferracci C; Baquillon G; Pattyn SR Acta Leprol; 1983; 1(4):233-5. PubMed ID: 6377799 [TBL] [Abstract][Full Text] [Related]
18. Search for effective short-course regimens for the treatment of leprosy. Pattyn SR Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183 [No Abstract] [Full Text] [Related]
19. Progress in the chemotherapy of leprosy. Grosset JH Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266 [No Abstract] [Full Text] [Related]
20. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411 [No Abstract] [Full Text] [Related] [Next] [New Search]